Biologically, the prominence of anti-AGR2 suggests that immune recognition of AGR2-expressing tumor cells reflects ER stress-related neoantigen exposure, whereas anti-TYMS responses may correspond to proliferative or DNA repair-linked antigenicity characteristic of early neoplastic transformation. The gene discussed is TYMS; the disease is neoplasm.